Rapid Influenza Diagnostic Test Market to Reach US$ 2.61 Billion by 2034: Fact.MR Report

Rockville, April 24, 2024 (GLOBE NEWSWIRE) — According to a new study by Fact.MR, the global rapid influenza diagnostic test market is set to reach a valuation of US$ 1.13 billion in 2024 and thereafter expand at a noteworthy CAGR of 8.7% from 2024 to 2034.

Sales of influenza test kits typically increase during specific seasons, such as the monsoon and cold periods, when individuals are more prone to experiencing health difficulties. Manufacturers are actively investing in enhancing the design, durability, and quality of these kits to prolong their lifespan, thus increasing their widespread adoption.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10041

The factors mentioned at the start of this piece have contributed to the popularity of influenza tests, prompting a significant number of individuals to purchase such test kits in advance to ensure preparedness during emergencies. The market is projected to exhibit growth as people become increasingly aware of the importance of timely testing, particularly in the wake of the COVID-19 pandemic.

Report Attribute	Details
Value Projection (2034)	US$ 2.61 Billion
Growth Rate (2024-2034)	8.7% CAGR
No. of pages	170 Pages
No. of Tables	84 Tables
No. of Figures	112 Figures

Key Takeaways from Market Study

• The global rapid influenza diagnostic test market is projected to expand at a CAGR of 8.7% through 2034.
• Global sales of rapid influenza diagnostic tests are estimated at US$ 1.13 billion in 2024.
• The market is forecasted to reach US$ 2.61 billion by 2034-end.
• The North American market is forecasted to expand at a CAGR of 8.7% through 2034.
• Nucleic acid is estimated to account for 28.4% market share in 2024.
• East Asia is projected to account for 16.4% of the global market share by 2034.

“The market is poised for decent growth driven by vulnerability of the increasing aging population to flu viruses, product enhancements, and investments in the enhancement of testing capabilities,” says a Fact.MR analyst.

Key Companies Profiled in This Report

• Becton
• Abbott Laboratories
• Quidel Corporation
• Hologic
• Thermo Fisher Scientific
• Dickinson and Company
• Meridian Bioscience Inc.
• DiaSorin SpA

Related Market Projections for 2034

Influenza Diagnostics Market	US$ 3.34 Billion
Arbovirus Testing Market	US$ 2.49 Billion
Antibiotic Residue Test Kits Market	US$ 350 Million

Technological Advancements in Influenza Diagnostics

Technological advancements are driving the growth of the rapid influenza diagnosis test market, as they enhance speed, accuracy, and efficacy in detecting and managing influenza. Increased trust and reliability in diagnostic testing are also aiding market expansion. The demand for these technologies is fueled by their accurate and speedy detection capabilities. Moreover, advancements have enabled the establishment of temporary testing camps in various settings, including rural areas, emergency rooms, and clinics, contributing to market accessibility and growth.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=10041

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the rapid influenza diagnostic test market for 2018 to 2023 and forecast statistics for 2024 to 2034.

The study divulges essential insights into the market based on principle (immunochromatographic assays, immunofluorescence assays, nucleic acid amplification test [NAAT]), test type (influenza A test, influenza B test, influenza A+B test), sample type (throat swab, nasal swab, nasal aspirate, nasal wash, nasopharyngeal swab, nasopharyngeal aspirate, nasopharyngeal wash), and end user (hospitals, diagnostic centers, nursing homes, office-based settings, urgent care centers, retail pharmacy clinics, schools & universities, public health camps), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA).

Explore More Related Studies Published by Fact.MR Research: 

Antibiotic Residue Test Kits Market: The global antibiotic residue test kits market size is currently being valued at US$ 184.5 million in 2023, and is projected to reach US$ 333.4 million by 2033-end.

Arbovirus Testing Market: Worldwide demand for arbovirus testing is predicted to increase at a 5.7% CAGR and reach a market value of US$ 2.49 billion by the end of 2034.

Influenza Diagnostic Market: The global influenza diagnostic market is estimated to be valued at US$ 1,806.5 million in 2024 and is forecast to reach a value of US$ 3,336.9 million by 2034, with a projected CAGR of 6.3% from 2024 to 2034.

About Fact.MR:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: [email protected]
Follow Us: LinkedIn | Twitter | Blog

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow